Mark Laughlin

A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

Karen L. Lindsay, Christian Trépo, Tobias Heintges et al. · Hepatology · 2001 · 665 citations

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Edward Gane, Stuart K. Roberts, Catherine AM Stedman et al. · The Lancet · 2010 · 335 citations

Hepatology, Hepatitis C, Viral Hepatitis +9

Interferon Alfa-2b in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Children: Efficacy, Safety, and Pharmacokinetics *

Regino P. González‐Peralta, Déirdre Kelly, Barbara Haber et al. · Hepatology · 2005 · 158 citations · Full text

Fetal alcohol spectrum disorder-associated depression: Evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model

Katharine E. Caldwell, Sheema Sheema, R. Paz et al. · Pharmacology Biochemistry and Behavior · 2008 · 110 citations · Full text

Psychiatry, Neurobiological Factor, Depression +9

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)

Marcelo Silva, Jorge Luis Poo, Frank Wagner et al. · Journal of Hepatology · 2006 · 106 citations

Hepatology, Hepatitis C, Viral Hepatitis +10